scispace - formally typeset
M

Michael Aidoo

Researcher at Centers for Disease Control and Prevention

Publications -  34
Citations -  1225

Michael Aidoo is an academic researcher from Centers for Disease Control and Prevention. The author has contributed to research in topics: Malaria & Plasmodium falciparum. The author has an hindex of 13, co-authored 30 publications receiving 1066 citations.

Papers
More filters
Journal ArticleDOI

Protective effects of the sickle cell gene against malaria morbidity and mortality

TL;DR: It is shown that HbAS provides significant protection against all-cause mortality, severe malarial anaemia, and high-density parasitaemia and this significant reduction in mortality was detected between the ages of 2 and 16 months, the highest risk period for severe malaria anaemia in this area.
Journal ArticleDOI

Tumor necrosis factor-alpha promoter variant 2 (TNF2) is associated with pre-term delivery, infant mortality, and malaria morbidity in western Kenya: Asembo Bay Cohort Project IX

TL;DR: In this article, the authors investigated the impact of the tumor necrosis factor-alpha (TNF-alpha) allele on malaria morbidity and mortality in young children who participated in an immuno-epidemiologic cohort study of malaria in an area of intense perennial Plasmodium falciparum transmission in western Kenya.
Journal ArticleDOI

Screening for Pfhrp2/3-Deleted Plasmodium falciparum, Non-falciparum, and Low-Density Malaria Infections by a Multiplex Antigen Assay.

TL;DR: High-throughput multiplex antigen detection can inexpensively screen for low-density P. falciparum, non-falcipareum, and Pfhrp2/3-deleted parasites to provide population-level antigen estimates and identify specimens requiring further molecular characterization.
Journal ArticleDOI

Central African hunters exposed to simian immunodeficiency virus.

TL;DR: HIV-seronegative Cameroonians with exposure to nonhuman primates were tested for simian immunodeficiency virus (SIV) infection and one person had strong humoral and weak cellular immune reactivity to SIVcol peptides.